• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.2019冠状病毒病与免疫抑制剂：印度皮肤科执业医师观点汇总
Dermatol Ther. 2020 Nov;33(6):e14036. doi: 10.1111/dth.14036. Epub 2020 Aug 14.
2
Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.系统性风湿病药物的调整：纽约市 COVID-19 大流行期间患者的观点。
Arthritis Care Res (Hoboken). 2021 Jun;73(6):909-917. doi: 10.1002/acr.24489.
3
Patients with specific skin disorders who are affected by COVID-19: What do experiences say about management strategies? A systematic review.患有特定皮肤疾病且受 COVID-19 影响的患者：管理策略的经验有何说法？系统评价。
Dermatol Ther. 2020 Nov;33(6):e13867. doi: 10.1111/dth.13867. Epub 2020 Jul 7.
4
Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients.度普利尤单抗治疗特应性皮炎：SARS-CoV-2感染患者的方案
Dermatol Ther. 2020 Nov;33(6):e14172. doi: 10.1111/dth.14172. Epub 2020 Sep 5.
5
COVID-19 Infection in Kidney Transplant Recipients in Italy: Management Issues in a Kidney Transplant Center.意大利肾移植受者中的新型冠状病毒肺炎感染：一家肾移植中心的管理问题
Exp Clin Transplant. 2021 Mar;19(3):284-286. doi: 10.6002/ect.2020.0151. Epub 2021 Jan 11.
6
Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era.大疱性类天疱疮在 COVID-19 大流行时代的治疗关注点。
Dermatol Ther. 2020 Nov;33(6):e13956. doi: 10.1111/dth.13956. Epub 2020 Jul 25.
7
COVID-19 and rheumatology: Reflecting on the first wave and preparing for the second wave.2019冠状病毒病与风湿病学：反思第一波疫情并为第二波疫情做准备
Int J Rheum Dis. 2021 Jan;24(1):7-9. doi: 10.1111/1756-185X.14062.
8
Management of childhood psoriasis in France. A national survey among general practitioners, pediatricians, and dermatologists.法国儿童银屑病的管理。全科医生、儿科医生和皮肤科医生的全国性调查。
Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12567. Epub 2017 Nov 28.
9
[Anti-aging medicine in dermatologic practice].[皮肤科临床中的抗衰老医学]
Hautarzt. 2005 Apr;56(4):321-2, 324-7. doi: 10.1007/s00105-005-0908-7.
10
Changing trends in dermatology practice during COVID-19 pandemic: A single tertiary center experience.COVID-19 大流行期间皮肤科实践的变化趋势：单中心经验。
Dermatol Ther. 2020 Nov;33(6):e14136. doi: 10.1111/dth.14136. Epub 2020 Sep 6.

本文引用的文献

1
IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid -19 Pandemic (IADVL Academy and IADVL Executive Committee).国际皮肤性病学会（IADVL）关于新冠疫情封锁解除后皮肤科诊疗实践的立场声明及建议（IADVL学院与IADVL执行委员会）
Indian Dermatol Online J. 2020 May 18;11(4):520-525. doi: 10.4103/idoj.IDOJ_334_20. eCollection 2020 Jul-Aug.
2
Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient.阿普司特作为治疗新冠肺炎的潜在选择：一名银屑病患者无感染症状。
Dermatol Ther. 2020 Jul;33(4):e13668. doi: 10.1111/dth.13668. Epub 2020 Jun 24.
3
COVID-19 and psoriasis: Should we fear for patients treated with biologics?COVID-19 与银屑病：接受生物制剂治疗的患者是否需要担心？
Dermatol Ther. 2020 Jul;33(4):e13434. doi: 10.1111/dth.13434. Epub 2020 May 5.
4
COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.COVID-19 与严重皮肤疾病免疫调节和生物制剂的使用：澳大利亚/新西兰共识声明。
Australas J Dermatol. 2020 Aug;61(3):210-216. doi: 10.1111/ajd.13313. Epub 2020 May 3.
5
Should biologics for psoriasis be interrupted in the era of COVID-19?在新冠疫情时代，银屑病生物制剂是否应中断使用？
J Am Acad Dermatol. 2020 May;82(5):1217-1218. doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.
6
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
7
Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule.阿普司特治疗银屑病及其他疾病：对一种小分子药物寄予厚望
Indian Dermatol Online J. 2019 Jan-Feb;10(1):1-12. doi: 10.4103/idoj.IDOJ_437_18.
8
Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.抗肿瘤坏死因子治疗与流感：客观看待。
Therap Adv Gastroenterol. 2010 May;3(3):173-7. doi: 10.1177/1756283X10366368.

COVID-19 and immunosuppressants: An opinion pool of practicing dermatologists of India.

作者信息

Ray Arunima, Debata Ipsita, Agrawal Ishan, Panda Maitreyee

机构信息

Department of Dermatology, IMS and SUM Hospital, Bhubaneswar, India.

出版信息

Dermatol Ther. 2020 Nov;33(6):e14036. doi: 10.1111/dth.14036. Epub 2020 Aug 14.

DOI:10.1111/dth.14036
PMID:32697015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7404382/
Abstract
摘要